MASI

Masimo Corporation

170.89

Top Statistics
Market Cap 9 B Forward PE 36.81 Revenue Growth 5.40 %
Current Ratio 2.01 Trailing PE 117.86 Earnings Growth -10.00 %
Profit Margins 3.85 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 49.51 Enterprise / Revenue 4.82 Price To Sales Trailing12 Months 4.48
Profitability
Profit Margins 3.85 % Operating Margins 5.96 %
Balance Sheet
Total Cash 158 M Total Cash Per Share 2.96 Total Debt 860 M
Total Debt To Equity 58.84 Current Ratio 2.01 Book Value Per Share 27.33
All Measures
Short Ratio 521.00 % Message Board Id finmb_31167 Fax 949 297 7001
Shares Short Prior Month 3 M Return On Equity 0.0574 City Irvine
Uuid e632c796-2b7c-370d-8fe5-85eca27f2bf0 Previous Close 172.26 First Trade Date Epoch Utc 1 B
Book Value 27.33 Beta 0.9730 Total Debt 860 M
Volume 419195 Price To Book 6.25 Fifty Two Week Low 91.60
Total Cash Per Share 2.96 Total Revenue 2 B Shares Short Previous Month Date 1 B
Target Median Price 174.50 Max Age 86400 Recommendation Mean 2.00
Sand P52 Week Change 0.3133 Operating Margins 5.96 % Last Dividend Value 1.00
Target Mean Price 169.01 Net Income To Common 78 M Short Percent Of Float 0.1136
Implied Shares Outstanding 53 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 630130 Average Volume10days 630130 Total Cash 158 M
Next Fiscal Year End 1 B Revenue Per Share 38.47 Held Percent Insiders 0.0819
Ebitda Margins 9.74 % Trailing PE 117.86 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 172.26 Target Low Price 128.12
Gmt Off Set Milliseconds -18000000 Fifty Day Average 147.03 Open 173.12
Free Cashflow 148 M State CA Dividend Yield 0.00 %
Return On Assets 0.0266 Time Zone Short Name EST Trailing Eps 1.45
Day Low 170.55 Address1 52 Discovery Shares Outstanding 53 M
Price Hint 2 Target High Price 190.00 Website https://www.masimo.com
52 Week Change 0.8226 Average Volume 721426 Earnings Quarterly Growth -7.50 %
Forward Eps 4.64 Recommendation Key buy Compensation As Of Epoch Date 1 B
Quick Ratio 94.60 % Is_sp_500 False Regular Market Day High 175.00
Profit Margins 3.85 % Debt To Equity 58.84 Fifty Two Week High 178.28
Day High 175.00 Shares Short 3 M Regular Market Open 173.12
Industry Key medical-devices Earnings Growth -10.00 % Enterprise To Revenue 4.82
Revenue Growth 5.40 % Shares Percent Shares Out 0.0624 Operating Cashflow 223 M
Currency USD Time Zone Full Name America/New_York Market Cap 9 B
Is_nasdaq_100 False Zip 92618 Quote Type EQUITY
Industry Medical Devices Ex Dividend Date 1 B Regular Market Day Low 170.55
Held Percent Institutions 0.9481 Long Name Masimo Corporation Current Price 170.89
Enterprise To Ebitda 49.51 Financial Currency USD Current Ratio 2.01
Gross Margins 50.05 % Industry Disp Medical Devices Number Of Analyst Opinions 8
Country United States Float Shares 44 M Two Hundred Day Average 130.91
Enterprise Value 9 B Price To Sales Trailing12 Months 4.48 Forward PE 36.81
Regular Market Volume 419195 Last Dividend Date 1 B Ebitda 199 M
Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha
Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide.

The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.

It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions.

In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.

com, amazon.

com, and shopify.

com.

Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.